REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Apteka N177 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Apteka N177 Profile Updated: September 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

MUP Apteka N177 is based in Russia, with the head office in Prokopyevsk. The company operates in the Pharmacies and Drug Stores industry. The company was established on October 23, 2002. The latest financial highlights indicate a net sales revenue increase of 13.92% in 2023. During that time, MUP Apteka N177’s total assets grew by 5.51%. The net profit margin of MUP Apteka N177 decreased by 0.01% in 2023.

Headquarters
Lenina, 20
Prokopyevsk; Kemerovo Oblast; Postal Code: 653039

Contact Details: Purchase the MUP Apteka N177 report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Apteka N177 report to view the information.
Registered Capital:
Purchase the MUP Apteka N177 report to view the information.
Incorporation Date:
October 23, 2002
Key Executives
Purchase this report to view the information.
Director of pharmacist
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Apteka N177 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
13.92%
Total operating revenue
13.92%
Operating profit (EBIT)
35.54%
Net Profit (Loss) for the Period
-15.29%
Total assets
5.51%
Total equity
-25.26%
Operating Profit Margin (ROS)
0.41%
Net Profit Margin
-0.01%
Return on Equity (ROE)
-11.77%
Quick Ratio
-0.03%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?